超声与超声引导下细针穿刺细胞学检查对甲状腺结节的诊断效能:ElaTION 试验数据
ElaTION 是一项在英格兰 18 家二级/三级医院开展的多中心实用性随机对照试验,比较弹性成像超声引导下细针穿刺细胞学检查(EUS-FNAC)与单纯超声引导下细针穿刺细胞学检查(US-FNAC)对甲状腺结节的诊断评估。本文报告次要结局,评估单纯超声(US)与 US-FNAC 的准确性以更新实践指南。982 名参与者中 688 名获得最终明确诊断并纳入分析;单纯超声敏感性与 US-FNAC 相同(0.91 [95%CI 0.85-0.97] vs 0.87 [95%CI 0.80-0.95],P=.37),但特异性显著更低(0.48 vs 0.67,P<.0001)。
要点
- 单纯超声敏感性与 US-FNAC 相同(0.91 vs 0.87,P=.37),特异性显著更低(0.48 vs 0.67,P<.0001)。
- 超声分类 U3、U4、U5 结节恶性风险分别为 68/304(22.4%)、43/83(51.8%)、29/38(76.3%)(P<.0001)。
- 超声与细胞学均良性(U2、Thy2)结节恶性率为 3/210(1.43%);结论提示对 Thy1 和 Thy3a 结节保守管理需谨慎。
核心结论
- 单纯超声似乎是甲状腺结节的有效诊断方法,证实了近期指南和英国甲状腺协会分类的推荐。
- 研究结果提示对无诊断性(Thy1/Bethesda I)和不典型(Thy3a/Bethesda III)结节现有保守管理推荐需谨慎。
- 在这些情况下,超声(U3-U5)特征可能有助于识别高风险亚组以进行更积极的管理。
研究设计与样本
- ElaTION 是一项在英格兰 18 家二级/三级医院开展的多中心实用性随机对照试验,比较 EUS-FNAC 与单纯 US-FNAC 对甲状腺结节的诊断评估。
- 纳入未接受过细针穿刺细胞学检查的单发或多发甲状腺结节成人;放射科医生对所有结节行单纯超声评估,以评估其与 US-FNAC 相比的准确性(敏感性和特异性)。
- 982 名参与者中 688 名获得最终明确诊断并纳入最终分析。
主要发现
- 单纯超声敏感性与 US-FNAC 相同:0.91(95%CI 0.85-0.97)vs 0.87(95%CI 0.80-0.95),P=.37。
- 单纯超声特异性显著低于 US-FNAC:0.48 vs 0.67,P<.0001。
- 超声分类为良性(U2)结节的组织学恶性率为 9/263(3.42%),细胞学良性(Thy2)为 15/353(4.25%),两者均良性(U2、Thy2)为 3/210(1.43%)。
- U3、U4、U5 结节恶性风险分别为 68/304(22.4%)、43/83(51.8%)、29/38(76.3%)(P<.0001)。
- 80/982(8%)患者尽管超声为 U3-U5 且 FNAC 为 Thy1(无诊断性)、无明确诊断仍被出院。
临床怎么用
- 作者认为单纯超声似乎是甲状腺结节的有效诊断方法,证实了近期指南和英国甲状腺协会分类的推荐。
- 作者提示对无诊断性(Thy1/Bethesda I)和不典型(Thy3a/Bethesda III)结节的现有保守管理推荐需谨慎。
- 作者认为在这些情况下超声(U3-U5)特征可能有助于识别高风险亚组以进行更积极的管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: ElaTION is a large multicenter pragmatic randomized controlled trial, performed in 18 secondary/tertiary hospitals across England, comparing elastography ultrasound-guided fine needle aspiration cytology (EUS-FNAC) with ultrasound-guided FNAC (US-FNAC) alone in the diagnostic assessment of thyroid nodules. Secondary trial outcomes, reported here, assessed the accuracy of ultrasound alone (US) compared with US-FNAC to inform and update current practice guidelines. METHODS: Adults with single or multiple thyroid nodules who had not undergone previous FNAC were eligible. Radiologists assessed all thyroid nodules using US alone, thereby enabling assessment of its accuracy (sensitivity and specificity) vs US-FNAC. RESULTS: Of the 982 participants, a final definitive diagnosis was obtained in 688, who were included in the final analyses. The sensitivity of US alone was the same as US-FNAC (0.91 [95% CI, 0.85-0.97] vs 0.87 [95% CI, 0.80-0.95] P = .37). US alone had statistically significant lower specificity than US-FNAC alone (0.48 vs 0.67 respectively, P < .0001). The malignancy rate on histology in a nodule classified as benign on ultrasound (U2) was 9/263 (3.42%) and on cytology (Thy2) was 15/353 (4.25%), whereas the malignancy rate in a nodule that was benign on both (U2, Thy2) was 3/210 (1.43%). Malignancy risk for U3, U4, and U5 nodules was 68/304 (22.4%), 43/83 (51.8%), and 29/38 (76.3%), respectively (P < .0001). Yet 80/982 (8%) patients were discharged despite having U3-U5 scans with Thy1 (nondiagnostic) FNAC and no definitive diagnosis.Malignancy risk was higher in smaller nodules: < 10 mm 23/60 (38.3%), 10-20 mm 46/162 (28.4%), and >20 mm 80/466 (17.2%) (P < .0001). Nodules with indeterminate cytology with atypical features (Thy3a) carried a similar malignancy risk to those with indeterminate cytology (Thy3/3f): 27/95 (28.4%) vs 42/113 (37.2%) respectively (P = .18). CONCLUSION: Ultrasound alone appears to be an effective diagnostic modality in thyroid nodules, confirming the recommendations of recent guidelines and the British Thyroid Association classification. However, findings also suggest caution regarding existing recommendations for conservative management of nondiagnostic (Thy1/Bethesda I) and atypical (Thy3a/Bethesda III) nodules. In those cases, ultrasound (U3-U5) features may help identify high-risk subgroups for more proactive management.
引用
- Mehanna H, Nankivell P, Boelaert K, et al. Diagnostic Performance of Ultrasound vs Ultrasound-Guided FNAC in Thyroid Nodules: Data From the ElaTION Trial. J Clin Endocrinol Metab. 2025. PMID: 39359050. doi:10.1210/clinem/dgae682
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。